Healthy Skepticism Library item: 3650

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Re: the promotion of erythromycin with bromhexine
1988 Nov;

Abstract:

Abbott markets Erybron, a combination of erythromycin and bromhexine, in the Philippines for bronchitis. MaLAM raises questions about the usefulness of the combination and the lack of safety information in the advertisements.

Keywords:
*analysis/Philippines/developing countries/Erybron/erythromycin/bromhexine/Abbott/antibiotics/MaLAM/Medical Lobby for Appropriate Marketing/ quality of information/ safety & risk information/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS